Answers are grounded in this paper and cite their sources.
Experiments were designed to demonstrate the synergism of low dose cyclophosphamide (CY), (15 mg/kg or 45 mg/M2) in combination with 5-aza-2'deoxycytidine (DAC). This dose of CY increased the cytotoxic response to DAC on L1210 tumor in mice by an additional 4 logs of L1210 cell kill or an approximate doubling of the response to DAC alone. These data support the hypothesis that CY at this low dose selectively inhibits suppressor t-cells which normally function to prevent the full cytotoxic potential of DAC from being realized.
No takes yet. Share an insight, caveat, or question.
Daniel S. Zaharko (1985) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: